Press Releases - 2025-12-15

Date	Title	Company
15-Dec-2025	Pharmanovia Announces Launch of Korjuny (Catumaxomab) in Germany, a First-in-class Treatment for Malignant Ascites	Businesswire
15-Dec-2025	AI unlocks unparalleled efficiency gains in Flare™ V11, Cresset’s leading software solution for digital molecular discovery	Cresset
15-Dec-2025	SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion	Businesswire
15-Dec-2025	GENESIS Pharma announces a new partnership with Otsuka Pharmaceutical Europe Ltd. for the commercialization of donidalorsen for hereditary angioedema in Central and Eastern Europe	Businesswire
15-Dec-2025	Drug Device Combination Products Market Analysis Highlights Increasing Adoption Across Laboratories and Research Institutions	Medi-Tech Insights
15-Dec-2025	Internal Fixation & Sealants Market Research Report, Size, Share, Growth and Forecast to 2030	Medi-Tech Insights
15-Dec-2025	Scottish Medicines Consortium (SMC) acceptance of use of Prometrium® (progesterone) 400mg soft vaginal capsules	Besins Healthcare UK
15-Dec-2025	Computer Vision in Healthcare Market 2030 \| Size, Share, Growth, Trends and Forecast	Medi-Tech Insights
15-Dec-2025	Medical Care Technologies, Inc. (OTC Pink:MDCE) Completes First AI Consumer App Targeting Deployment Across 100+ Countries and 30 Languages	ACCESS Newswire
15-Dec-2025	Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults	ACCESS Newswire
15-Dec-2025	IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines	ACCESS Newswire
15-Dec-2025	Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)	ACCESS Newswire
15-Dec-2025	Novadip recruits first pediatric patients in pivotal phase 3 trial of tissue regenerative treatment NVD003 in congenital pseudoarthrosis of the tibia	Andrew Lloyd Associates
15-Dec-2025	ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies	ProteoNic 2G UNic® Technology
15-Dec-2025	FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial	Neurizon
15-Dec-2025	Budget speculation kills growth	Institute of Economic Affairs
15-Dec-2025	Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten	Everest Medicines Limited
15-Dec-2025	Global Minimally Invasive Surgery Market to Reach US$211.24 Billion by 2033, Says FutureWise Research	Futurewise Research
15-Dec-2025	EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)	ACCESS Newswire
15-Dec-2025	Amphastar Announces FDA Approval for Teriparatide Injection	ACCESS Newswire